isoxazoles has been researched along with Diabetic Neuropathies in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arslan, R; Bektas, N; Ozturk, Y | 1 |
Albrecht, C; Berry, AK; Betageri, R; Ceci, A; Ermann, M; Gemkow, MJ; Hickey, ER; Jenkins, JE; Khor, S; Nagaraja, NV; Riether, D; Romig, H; Sauer, A; Thomson, DS; Wu, L; Zindell, R | 1 |
Derry, S; Lunn, MP; Moore, RA; Wiffen, PJ | 1 |
Murakami, T; Ono, H; Tanabe, M | 1 |
Kakimoto, K; Shibata, T; Takeuchi, S; Wakitani, K; Yokota, S; Yonemori, F | 1 |
Shinkai, H | 1 |
2 review(s) available for isoxazoles and Diabetic Neuropathies
Article | Year |
---|---|
Zonisamide for neuropathic pain in adults.
Topics: Adult; Analgesics; Anticonvulsants; Diabetic Neuropathies; Female; Humans; Isoxazoles; Male; Middle Aged; Neuralgia; Zonisamide | 2015 |
[The chemical structure and pharmacological properties of a novel isoxazolidinedione insulin sensitizer, JTT-501].
Topics: Animals; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Neuropathies; Glucose Transporter Type 4; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Isoxazoles; Monosaccharide Transport Proteins; Muscle Proteins; Rats; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Transcription Factors | 2001 |
4 other study(ies) available for isoxazoles and Diabetic Neuropathies
Article | Year |
---|---|
Zonisamide: Antihyperalgesic efficacy, the role of serotonergic receptors on efficacy in a rat model for painful diabetic neuropathy.
Topics: Animals; Anticonvulsants; Carbamazepine; Diabetic Neuropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hyperalgesia; Isoxazoles; Ketanserin; Male; Morphine; Ondansetron; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin, 5-HT3; Streptozocin; Zonisamide | 2014 |
Selective CB2 receptor agonists. Part 2: Structure-activity relationship studies and optimization of proline-based compounds.
Topics: Animals; Diabetic Neuropathies; Half-Life; Humans; Isoxazoles; Ligands; Male; Microsomes, Liver; Proline; Protein Binding; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Solubility; Structure-Activity Relationship | 2015 |
Zonisamide suppresses pain symptoms of formalin-induced inflammatory and streptozotocin-induced diabetic neuropathy.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Formaldehyde; Inflammation; Isoxazoles; Male; Mice; Pain; Streptozocin; Zonisamide | 2008 |
Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.
Topics: Absorptiometry, Photon; Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Cataract; Chromans; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathies; Eating; Hypoglycemic Agents; Isoxazoles; Male; Neural Conduction; Obesity; Pancreas; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone | 2000 |